Recent Business Highlights Exhibit 99.1 BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results Sunnyvale, Calif. – August 11, 2025 - BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the second quarter of 2025 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2025 with the Securities and Exchange Commission. The Co ...